2, 4-Pyrimidinediamines Useful In The Treatment Of Neoplastic Diseases, Inflammatory And Immune System Disorders
申请人:Garcia-Echeverria Carlos
公开号:US20080132504A1
公开(公告)日:2008-06-05
Novel pyrimidine derivatives of formula I
to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them
式I的新型嘧啶衍生物及其制备方法,它们的药用价值以及包含它们的药物组合物。
PYRIMIDINE DERIVATIVES
申请人:Garcia-Echeverria Carlos
公开号:US20110201606A1
公开(公告)日:2011-08-18
Novel pyrimidine derivatives of formula I
to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them
式I的新型嘧啶衍生物及其制备方法,其用作药物和含有它们的药物组合物。
2,4-PYRIMIDINEDIAMINES USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES, INFLAMMATORY AND IMMUNE SYSTEM DISORDERS
申请人:Garcia-Echeverria Carlos
公开号:US20110098280A1
公开(公告)日:2011-04-28
Novel pyrimidine derivatives of formula I
to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them.
I类新型嘧啶衍生物的制备方法,以及它们作为药物和药物组合物的用途。
2,4-Di(phenylamino)-pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
申请人:Novartis AG
公开号:EP2287156A1
公开(公告)日:2011-02-23
Novel pyrimidine derivatives of formula (I) and their use for the manufacture of a medicament for the treatment or prevention of a disease which responds to inhibition of FAK and/or ALK and/or ZAP-70 and/or IGF-IR.
in which: n' is selected from 1,2 and 3;
R'1is selected from phenyl, pyridinyl, pyrazolyl and pyrimidinyl;
and R'2 and R'3 are as described herein.